CVS Health Corporation (NYSE:CVS) is included among the 10 High Quality Stocks to Buy According to Hedge Funds.
On May 13, Bernstein raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $106 from $94
It reiterated an Outperform rating on the stock. The firm said it still sees CVS as well-positioned to benefit from the Medicare Advantage turnaround. It also pointed to the possibility of steadier earnings in the company’s pharmacy and pharmacy benefit manager businesses following PBM reform.
Bernstein believes the PBM bill and the first Federal Trade Commission settlement earlier this year largely marked the completion of PBM reform. In its view, that served as a clearing event and reduced uncertainty around CVS’ turnaround efforts. During the company’s Q1 2026 earnings call, CEO, President, and Chairman J.